Esperion Therapeutics, Inc. Quarterly Quick Ratio in % from Q3 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
Esperion Therapeutics, Inc. quarterly Quick Ratio history and growth rate from Q3 2020 to Q3 2024.
  • Esperion Therapeutics, Inc. Quick Ratio for the quarter ending September 30, 2024 was 45.8 %, a 15.5% increase year-over-year.
Quick Ratio, Quarterly (%)
Quick Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 45.8 +6.14 +15.5% Sep 30, 2024
Q2 2024 43.3 +3.64 +9.17% Jun 30, 2024
Q1 2024 41.7 +3.86 +10.2% Mar 31, 2024
Q4 2023 40.7 +2.12 +5.5% Dec 31, 2023
Q3 2023 39.7 -0.96 -2.36% Sep 30, 2023
Q2 2023 39.7 -2.85 -6.7% Jun 30, 2023
Q1 2023 37.8 -2.9 -7.12% Mar 31, 2023
Q4 2022 38.6 +4.85 +14.4% Dec 31, 2022
Q3 2022 40.6 +14.1 +52.9% Sep 30, 2022
Q2 2022 42.6 +22.9 +116% Jun 30, 2022
Q1 2022 40.7 +25.5 +168% Mar 31, 2022
Q4 2021 33.7 +23 +213% Dec 31, 2021
Q3 2021 26.6 +20.2 +315% Sep 30, 2021
Q2 2021 19.7 Jun 30, 2021
Q1 2021 15.2 Mar 31, 2021
Q4 2020 10.8 Dec 31, 2020
Q3 2020 6.4 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.